NIH symposium summary: organ preservation therapies for squamous cancers of the head and neck.
This symposium, sponsored by the NIH Office of Rare Diseases, the National Cancer Institute, the National Institute of Deafness and Other Communication Disorders, and the National Institute of Dental and Craniofacial Diseases, reviewed the current status of organ preservation therapies for head and neck cancers, as well as promising newer approaches for therapy and for toxicity amelioration.
Conley
B A
BA
Diagnostics Research Branch, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20852, USA. conleyb@mail.nih.gov
Cumberlin
R
R
Sandberg
A
A
Solomon
B
B
Van Waes
C
C
D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans